Latest Articles

Publication Date
Farmer Wants A Wife fan favourites expecting first child - MSN

Farmer Wants A Wife fan favourites expecting first child MSN

Published: Feb. 18, 2026, 4:05 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Priva - PharmiWeb.com

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Priva PharmiWeb.com

Published: Feb. 18, 2026, 4:05 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - PharmiWeb.com

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement PharmiWeb.com

Published: Feb. 18, 2026, 4:05 p.m.
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Feb. 18, 2026, 3:18 p.m.
Kaillie Humphries’ husband, Travis Armbruster: Five fast facts you need to know - MSN

Kaillie Humphries’ husband, Travis Armbruster: Five fast facts you need to know MSN

Published: Feb. 18, 2026, 11:51 a.m.
Hormone‑disrupting chemicals found in sanitary pad brands sold in SA - SABC News

Hormone‑disrupting chemicals found in sanitary pad brands sold in SA SABC News

Published: Feb. 18, 2026, 8:41 a.m.
Did you know men can get endometriosis too? UK physician explains why this happens and the role of hormonal factors | Health - Hindustan Times

Did you know men can get endometriosis too? UK physician explains why this happens and the role of hormonal factors | Health Hindustan Times

Published: Feb. 18, 2026, 6:12 a.m.
The value of a non-invasive bladder sensitivity paradigm in chronic pelvic pain.

We explore bladder sensitivity profiles in females with chronic pelvic pain, using a non-invasive bladder sensitivity paradigm. We aim to determine how profiles differ between groups defined by symptoms; groups …

Published: Feb. 18, 2026, midnight
Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair.

Endometriosis is a chronic, hormone-dependent disorder characterized by ectopic implantation of endometrial tissue, often accompanied by pain and infertility. Although the progesterone receptor modulator RU486 is effective for pain relief, …

Published: Feb. 18, 2026, midnight
UFS study finds hormone-disrupting chemicals in SA menstrual products - East Coast Radio

UFS study finds hormone-disrupting chemicals in SA menstrual products East Coast Radio

Published: Feb. 17, 2026, 1:56 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!